A drugmaker has announced it will start selling generic versions of a generic version of its own medication.
The U.S. Food and Drug Administration said Monday it will begin issuing the generic versions as a way to make the drug more accessible to consumers, including those who want the pill to work as a drug for their conditions.
Generic versions of the painkiller oxycodone, the first to be approved in the United States, will be available by the end of the year, but the generic version is expected to cost about $1,500 a month.
If patients don’t have access to a generic painkiller, they can still get a brand-name pill for about $300, a spokeswoman for the company said in a statement.
“As of December 31, 2016, there were about 4.6 million oxycodones in the U..
S., or about one-third of the total market, according to a report by Medscape, which provides the data,” she said.
As a result of the generic pill, the generic drug maker will sell more oxycodoned products than it will the brand-new generic version, which is expected in 2018.
An earlier version of the same story incorrectly stated the cost of the brand new oxycodONE pills.